Temporal Arteritis
11
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA
Clonal Hematopoiesis in Giant Cell Arteritis
PatientSpot Formerly Known as ArthritisPower
Aetiology of TemporaL Arteritis Study
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Ustekinumab for the Treatment of Giant Cell Arteritis
Journey of Patients With Vasculitis From First Symptom to Diagnosis
Impact of Vasculitis on Employment and Income
Diagnostic Study of Temporal Arteritis
MRI Superficial Temporal Artery
Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis